Oxford spinout spies the hidden mechanics of DNA and disease with single-pair resolution method

Nucleome Therapeutics has found a new way to depict and analyze DNA with super-fine resolution, allowing them to peer into “the dark matter of the human genome” and the molecular basis of many diseases. What they hope to find are answers about COVID-19 severity—and new drug targets for multiple sclerosis and rheumatoid arthritis.

Related Keywords

James Davies ,Danuta Jeziorska ,University Of Oxford ,Weatherall Institute Of Molecular Medicine ,Molecular Medicine ,Coronavirus ,Nucleome Therapeutics ,Covid 19 ,Na Sequencing ,Diagnostic Tests ,Multiple Sclerosis ,Rheumatoid Arthritis ,Medtech ,ஜேம்ஸ் டேவிஸ் ,பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் ,மூலக்கூறு மருந்து ,மெதிதேச் ,